News | Beyond Fertility: New Findings on GnRH and Cognition
A study found that gonadotropin-releasing hormone (GnRH) therapy may improve cognitive function in men with Down syndrome (DS), in addition to its role in reproduction. The finding offers a new direction for research into cognitive impairment in DS.
Down syndrome, or trisomy 21, is one of the most common genetic causes of intellectual disability. Incidence rises with maternal age and is about 1/30 among women aged 45 or older. Adults with DS may develop symptoms resembling early-onset Alzheimer's disease and gradually lose their sense of smell. Men with DS may also have impaired sexual maturation. Treatment options for DS-related cognitive and olfactory impairment remain limited.
Why Might GnRH Affect Cognition?
GnRH is closely linked to fertility and gonadal development, but researchers found that it may also play an important role in higher brain functions such as cognition. Previous studies have linked loss of smell and male infertility to GnRH deficiency, but its role in DS pathology remains unclear.
Maria Manfredi-Lozano and colleagues at IDIBAPS in Barcelona, Spain, found abnormalities in microRNAs that regulate GnRH production in a DS mouse model, impairing GnRH-secreting neurons. Restoring GnRH function through epigenetic, cellular, chemical, and pharmacological interventions reversed olfactory and cognitive deficits in the mice. Similar improvements were observed in an Alzheimer's disease mouse model.
Clinical Trial: GnRH Therapy Improves Cognition in Men with DS
Following positive animal results, researchers conducted a small clinical trial of GnRH therapy in 7 adult men with DS.
Results showed:
✅ 6 patients had clear cognitive improvements in memory, attention, and executive function;
✅ 1 patient showed no clear change;
✅ Olfactory function did not improve, suggesting GnRH may primarily affect cognition rather than smell.
The team believes this may open new possibilities for treating cognitive impairment in DS, although larger trials are needed to confirm long-term efficacy and safety.
Expert View: GnRH Research May Reshape DS Treatment
In an accompanying commentary, Professor Hanne Hoffmann of Michigan State University said the findings broaden the traditional view of GnRH from a reproductive hormone to a factor in cognition, offering new directions for research into Down syndrome and neurological diseases such as Alzheimer's.
Research Outlook: Could GnRH Become a New DS Treatment?
Although the research is preliminary, the cognitive improvements are encouraging. Researchers plan to:
Expand clinical trials to further assess efficacy and safety;
Investigate how GnRH affects cognition;
Study its effects in women with DS to assess broader applicability.
This research may offer new treatment possibilities for people with Down syndrome and other cognitive disorders.
News | Beyond Fertility: New Findings on GnRH and Cognition
News | Beyond Fertility: New Findings on GnRH and Cognition
A study found that gonadotropin-releasing hormone (GnRH) therapy may improve cognitive function in men with Down syndrome (DS), in addition to its role in reproduction. The finding offers a new direction for research into cognitive impairment in DS.
Down syndrome, or trisomy 21, is one of the most common genetic causes of intellectual disability. Incidence rises with maternal age and is about 1/30 among women aged 45 or older. Adults with DS may develop symptoms resembling early-onset Alzheimer's disease and gradually lose their sense of smell. Men with DS may also have impaired sexual maturation. Treatment options for DS-related cognitive and olfactory impairment remain limited.
Why Might GnRH Affect Cognition?
GnRH is closely linked to fertility and gonadal development, but researchers found that it may also play an important role in higher brain functions such as cognition. Previous studies have linked loss of smell and male infertility to GnRH deficiency, but its role in DS pathology remains unclear.
Maria Manfredi-Lozano and colleagues at IDIBAPS in Barcelona, Spain, found abnormalities in microRNAs that regulate GnRH production in a DS mouse model, impairing GnRH-secreting neurons. Restoring GnRH function through epigenetic, cellular, chemical, and pharmacological interventions reversed olfactory and cognitive deficits in the mice. Similar improvements were observed in an Alzheimer's disease mouse model.
Clinical Trial: GnRH Therapy Improves Cognition in Men with DS
Following positive animal results, researchers conducted a small clinical trial of GnRH therapy in 7 adult men with DS.
Results showed:
✅ 6 patients had clear cognitive improvements in memory, attention, and executive function;
✅ 1 patient showed no clear change;
✅ Olfactory function did not improve, suggesting GnRH may primarily affect cognition rather than smell.
The team believes this may open new possibilities for treating cognitive impairment in DS, although larger trials are needed to confirm long-term efficacy and safety.
Expert View: GnRH Research May Reshape DS Treatment
In an accompanying commentary, Professor Hanne Hoffmann of Michigan State University said the findings broaden the traditional view of GnRH from a reproductive hormone to a factor in cognition, offering new directions for research into Down syndrome and neurological diseases such as Alzheimer's.
Research Outlook: Could GnRH Become a New DS Treatment?
Although the research is preliminary, the cognitive improvements are encouraging. Researchers plan to:
Expand clinical trials to further assess efficacy and safety;
Investigate how GnRH affects cognition;
Study its effects in women with DS to assess broader applicability.
This research may offer new treatment possibilities for people with Down syndrome and other cognitive disorders.
Source:
Collected online